SEC Form 4 · accession 0001209191-19-012249
Principia Biopharma Inc. · PRNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John W Smither
Director
Period of report
Feb 19, 2019
Accepted (ET)
Feb 21, 2019 · 6:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510487
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $30.30 | Feb 19, 2019 | A | 20,475 | A | — | Feb 18, 2029 | Common Stock | 20,475 | 20,475 | D |
Explanation of responses
- F1The stock option vests in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.